Topic Intelligence
Articles and insights tagged Water on FAQsIR.
BioLargo has commenced alpha testing of a portable PFAS test kit developed by Verralize, aiming to improve the efficiency of water treatment processes and enhance public health safety.
BioLargo has reported significant financial and operational developments for the year ending December 31, 2025. Despite facing adversity, the company achieved notable growth in certain sectors.
BioLargo, Inc. will present its Q4 2025 earnings results during a webcast and conference call on March 5, 2026, aimed at discussing financial performance and recent milestones.
BioLargo, Inc. has confirmed remarkable effectiveness in removing ultrashort-chain PFAS, including TFA, through its innovative Aqueous Electrostatic Concentration technology, positioning the company as a leader in PFAS treatment.
BioLargo will exhibit at WEFTEC 2025, featuring its Aqueous Electrostatic Concentration Solution for PFAS removal. The event takes place from September 29 to October 1 in Chicago.
BioLargo, Inc. has been invited to present its industry-leading PFAS removal technology at a significant water management conference, highlighting its advancements in environmental solutions.
The installation of BioLargo's AEC PFAS treatment system at Lake Stockholm marks a significant advancement in providing clean drinking water to the community, effectively addressing complex PFAS contaminants.
BioLargo has made significant strides in 2025, showcasing advancements across its subsidiaries. The company’s commitment to sustainable technology and environmental challenges positions it for future success.